Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.

Int J Oncol 2008 Oct;33(4):887-92

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, A-1090 Vienna, Austria.

Piceatannol (3,3',4,5'-tetrahydroxy-trans-stilbene; PCA) is a naturally occurring metabolite of resveratrol (3,4',5-trihydroxy-trans-stilbene; RV). In this study, we identified additional biochemical targets of PCA in human HL-60 promyelocytic leukemia cells. Incubation with PCA led to a significant proportion of apoptotic cells and caused an arrest in the G2-M phase of the cell cycle. PCA depleted intracellular dCTP and dGTP pools, and inhibited the incorporation of 14C-labeled cytidine into DNA. PCA significantly abolished all NTP pools, and sequential treatment with PCA and Ara-C yielded synergistic growth inhibitory effects because of remarkably increased Ara-CTP formation after PCA preincubation. Due to these promising results, PCA may support conventional chemotherapy of human malignancies and therefore, deserves further preclinical and in vivo testing.

Download full-text PDF

Source
October 2008
13 Reads

Publication Analysis

Top Keywords

hl-60 promyelocytic
8
pca
8
human hl-60
8
promyelocytic leukemia
8
g2-m phase
4
preincubation promising
4
arrest g2-m
4
promising pca
4
treatment pca
4
phase cell
4
cycle pca
4
cell cycle
4
pca preincubation
4
caused arrest
4
sequential treatment
4
support conventional
4
proportion apoptotic
4
synergistic growth
4
apoptotic cells
4
pca led
4

Similar Publications